Search

Bo Peng

Examiner (ID: 19836)

Most Active Art Unit
1648
Art Unit(s)
1648, CQIC, 4171, 4111
Total Applications
343
Issued Applications
135
Pending Applications
38
Abandoned Applications
170

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7103835 [patent_doc_number] => 20050106561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B' [patent_app_type] => utility [patent_app_number] => 10/913910 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4219 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106561.pdf [firstpage_image] =>[orig_patent_app_number] => 10913910 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/913910
Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B Aug 5, 2004 Abandoned
Array ( [id] => 7185226 [patent_doc_number] => 20050191747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Recombinant bovine immunodeficiency virus based gene transfer system' [patent_app_type] => utility [patent_app_number] => 10/910293 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26893 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191747.pdf [firstpage_image] =>[orig_patent_app_number] => 10910293 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/910293
Recombinant bovine immunodeficiency virus based gene transfer system Aug 3, 2004 Abandoned
Array ( [id] => 7116568 [patent_doc_number] => 20050069869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'SARS nucleic acids, proteins, antibodies, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/911838 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 29049 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069869.pdf [firstpage_image] =>[orig_patent_app_number] => 10911838 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/911838
SARS nucleic acids, proteins, antibodies, and uses thereof Aug 3, 2004 Issued
Array ( [id] => 7033131 [patent_doc_number] => 20050031640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma' [patent_app_type] => utility [patent_app_number] => 10/910596 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5229 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031640.pdf [firstpage_image] =>[orig_patent_app_number] => 10910596 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/910596
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma Aug 2, 2004 Issued
Array ( [id] => 281944 [patent_doc_number] => 07553944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Human virus causing respiratory tract infection and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/895064 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 9 [patent_no_of_words] => 19390 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553944.pdf [firstpage_image] =>[orig_patent_app_number] => 10895064 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/895064
Human virus causing respiratory tract infection and uses thereof Jul 20, 2004 Issued
Array ( [id] => 6938991 [patent_doc_number] => 20050112554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/888401 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 21609 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112554.pdf [firstpage_image] =>[orig_patent_app_number] => 10888401 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/888401
Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof Jul 8, 2004 Issued
Array ( [id] => 6938581 [patent_doc_number] => 20050112144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Hepatitis A vaccines' [patent_app_type] => utility [patent_app_number] => 10/878094 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112144.pdf [firstpage_image] =>[orig_patent_app_number] => 10878094 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/878094
Hepatitis A vaccines Jun 27, 2004 Abandoned
Array ( [id] => 5045973 [patent_doc_number] => 20070264646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Hbv Particles Containing Hbv-Rna' [patent_app_type] => utility [patent_app_number] => 11/630254 [patent_app_country] => US [patent_app_date] => 2004-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3275 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264646.pdf [firstpage_image] =>[orig_patent_app_number] => 11630254 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630254
Hbv Particles Containing Hbv-Rna Jun 21, 2004 Abandoned
Array ( [id] => 7275103 [patent_doc_number] => 20040234554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'HBV core antigen particles with multiple immunogenic components attached via peptide ligands' [patent_app_type] => new [patent_app_number] => 10/872550 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10079 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234554.pdf [firstpage_image] =>[orig_patent_app_number] => 10872550 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/872550
HBV core antigen particles with multiple immunogenic components attached via peptide ligands Jun 20, 2004 Issued
Array ( [id] => 7275091 [patent_doc_number] => 20040234542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications' [patent_app_type] => new [patent_app_number] => 10/476777 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 9145 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234542.pdf [firstpage_image] =>[orig_patent_app_number] => 10476777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/476777
Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications Jun 6, 2004 Abandoned
Array ( [id] => 7152638 [patent_doc_number] => 20050025788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Systemic delivery of non-viral vector expressing SARS viral genomic vaccine' [patent_app_type] => utility [patent_app_number] => 10/860119 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6080 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025788.pdf [firstpage_image] =>[orig_patent_app_number] => 10860119 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860119
Systemic delivery of non-viral vector expressing SARS viral genomic vaccine Jun 3, 2004 Abandoned
Array ( [id] => 7252581 [patent_doc_number] => 20040259243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Cells for detection of enteroviruses' [patent_app_type] => new [patent_app_number] => 10/861724 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18079 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259243.pdf [firstpage_image] =>[orig_patent_app_number] => 10861724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/861724
Cells for detection of enteroviruses Jun 2, 2004 Issued
Array ( [id] => 7372152 [patent_doc_number] => 20040219171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'In ovo protection against infectious bronchitis' [patent_app_type] => new [patent_app_number] => 10/858277 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4820 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219171.pdf [firstpage_image] =>[orig_patent_app_number] => 10858277 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858277
Ovo immunization against infectious bronchitis May 31, 2004 Issued
Array ( [id] => 6931244 [patent_doc_number] => 20050282279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Expression vector encoding coronavirus-like particle' [patent_app_type] => utility [patent_app_number] => 10/855490 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5539 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282279.pdf [firstpage_image] =>[orig_patent_app_number] => 10855490 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855490
Expression vector encoding coronavirus-like particle May 27, 2004 Abandoned
Array ( [id] => 5732306 [patent_doc_number] => 20060257423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Intracutaneous injection combined vaccine included hevac and bcg for and preparation method' [patent_app_type] => utility [patent_app_number] => 10/559471 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3263 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257423.pdf [firstpage_image] =>[orig_patent_app_number] => 10559471 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559471
HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof May 25, 2004 Issued
Array ( [id] => 698337 [patent_doc_number] => 07067249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Inhibition of hepatitis B virus (HBV) replication by RNA interference' [patent_app_type] => utility [patent_app_number] => 10/848736 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11978 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067249.pdf [firstpage_image] =>[orig_patent_app_number] => 10848736 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848736
Inhibition of hepatitis B virus (HBV) replication by RNA interference May 18, 2004 Issued
Array ( [id] => 7426656 [patent_doc_number] => 20040265798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Methods and compositions related to high-titer pseudotyped retroviruses' [patent_app_type] => new [patent_app_number] => 10/845253 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23387 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265798.pdf [firstpage_image] =>[orig_patent_app_number] => 10845253 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845253
Methods and compositions related to high-titer pseudotyped retroviruses May 12, 2004 Issued
Array ( [id] => 7689505 [patent_doc_number] => 20070105193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Severe acute respiratory syndrome DNA vaccine compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/843656 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 70388 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105193.pdf [firstpage_image] =>[orig_patent_app_number] => 10843656 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/843656
Severe acute respiratory syndrome DNA compositions and methods of use May 11, 2004 Issued
Array ( [id] => 5040654 [patent_doc_number] => 20070092936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Severe acute respiratory syndrome' [patent_app_type] => utility [patent_app_number] => 10/553844 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 2922 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092936.pdf [firstpage_image] =>[orig_patent_app_number] => 10553844 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553844
Severe acute respiratory syndrome May 9, 2004 Abandoned
Array ( [id] => 7421643 [patent_doc_number] => 20040229219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (SARS)' [patent_app_type] => new [patent_app_number] => 10/834666 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21416 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229219.pdf [firstpage_image] =>[orig_patent_app_number] => 10834666 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/834666
Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (SARS) Apr 28, 2004 Abandoned
Menu